Therapeutic Education Program for Laryngectomised Patients and Their Close Relations
NCT02903875 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 40
Last updated 2016-09-16
Summary
The therapeutic education of patients and their close relations is, as yet, poorly developed in France in the field of oncology, in particular for cancers of the upper aerodigestive tract. In the case of pharyngeal and laryngeal cancer, total laryngectomy associated with radiotherapy remains a reference treatment for advanced stage cancers. This mutilating surgical procedure has a major impact on the patient's life, due to its physical and functional sequelae. Its psychosocial consequences are also important, owing to the biographical disruption and the identity-related metamorphoses associated with illness and its treatment, which alter the quality of life not only of patients, but also of their close relations. Currently, care for laryngectomised patients consists essentially in informing and educating them on certain technical procedures during hospital admission. New voice education can be a long process and often involves the intervention of a speech therapist, who serves as the link between the patient and the hospital care team. These healthcare modalities often insufficiently account for the social, environmental and personal factors that interact in health-related problems.
The aim is to design, implement and evaluate a patient therapeutic education (PTE) programme, for laryngectomised patients and their close relations, aimed at improving their quality of life.
The research will be conducted over three phases:
The first phase, referred to as the "pilot" phase, will include exploratory, observational and retrospective analysis aimed at developing knowledge on the consequences of laryngectomy on the quality of life of patients and their close relations, the strengths and weaknesses of current practice in patient support and the needs expressed by the players involved (patients, relations, professional carers). This analysis will be conducted via interviews with patients and their close relations and focus groups with the healthcare professionals involved in patient care and support (hospital and independent). This first phase will enable the pluridisciplinary design of a therapeutic education programme for laryngectomised patients and their close relations which will be tested in the study's principle coordinating centre. The method defined thus is in keeping with quality criteria set by the HAS specifying that the PTE should focus on the patient, be scientifically justified, and be developed by a pluridisciplinary group reuniting representatives of patients or patient associations.
The second phase, referred to as the prospective intervention "replication" phase, aims at evaluating the programme's transferability and quality in three centres. The centres participating in this second phase already have experience in the development of PTE programmes and will be involved in the workgroup entrusted with the design of the PETAL programme during phase 1.
The third phase, referred to as the "randomised" multicentric comparative intervention phase, should enable us to assess the benefits of the developed PTE programme on the quality of life of patients and their close relations.
This is a pluridisciplinary study via which we hope to improve the quality of life of laryngectomised patients and their close relations through the design and the sustainable deployment of an innovative PTE programme in France and Belgium. This project also aims at reinforcing town-hospital links to improve help, follow-up and support for patients and their close relations, as well as dialogue between healthcare professionals.
Conditions
Interventions
- OTHER
-
Patient therapeutic education (PTE) programme
Sponsors & Collaborators
-
University Hospital, Caen
lead OTHER -
University of Lille Nord de France
collaborator OTHER -
CERFEP CARSAT Nord-Picardie
collaborator UNKNOWN -
INSERM U1086 Cancers et Préventions
collaborator UNKNOWN
Eligibility
- Min Age
- 18 Years
- Max Age
- 70 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2013-04-30
- Primary Completion
- 2017-12-31
- Completion
- 2018-07-31
Countries
- France
Study Locations
More Related Trials
-
Radiation Therapy With or Without Chemotherapy in Treating Patients With Advanced Cancer of the Larynx
NCT00002496 ·Status: COMPLETED ·Phase: PHASE3
-
Adaptive, Image-guided, Intensity-modulated Radiotherapy for Head and Neck Cancer in the Reduced Volumes of Elective Neck
NCT01287390 ·Status: COMPLETED ·Phase: PHASE2
-
Radiofrequency in Differentiated Thyroid Cancer Metastatic Lymph Node: Prospective Study of Safety and Efficacy
NCT03416686 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Pilot Study of a Catheter-based Ultrasound Hyperthermia System
NCT00911079 ·Status: TERMINATED ·Phase: NA
-
Hypofractionated Radiotherapy With Hyperthermia in Unresectable or Marginally Resectable Soft Tissue Sarcomas
NCT03989596 ·Status: UNKNOWN ·Phase: PHASE2
-
Trial Comparing Two Protocols of re Irradiation in an Irradiated Area for Carcinoma of the Upper Aerodigestive Tract
NCT01211938 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Stereotactic Ablative Radiotherapy for Oligo-Progressive Disease REfractory to Systemic Therapy in Metastatic Cancer
NCT04989725 ·Status: RECRUITING ·Phase: PHASE2
-
Yttrium-90 Radioembolization Using Glass Microspheres (TheraSphere) for Patients With Liver Metastases
NCT01290536 ·Status: COMPLETED ·Phase: PHASE2
-
TPF Followed by Cetuximab and IMRT Plus Carbon Ion Boost for Locally Advanced Head and Neck Tumors
NCT01245985 ·Status: TERMINATED ·Phase: PHASE2
-
Stereotactic Ablative Radiotherapy for Early-stage Glottic Larynx Cancer
NCT03548285 ·Status: COMPLETED ·Phase: NA
-
Adaptative MR-Guided Stereotactic Body Radiotherapy of Liver Tumors
NCT04242342 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Cryoablation in Combination (or Not) With Pembrolizumab and Pemetrexed-carboplatin in 1st-line Treatment for Patients With Metastatic Lung Adenocarcinoma
NCT04339218 ·Status: RECRUITING ·Phase: PHASE3
-
Radiotherapy in Association With Cetuximab in Patients Treated for an Epidermoid Cancer
NCT01647555 ·Status: COMPLETED
-
Palliative Radiotherapy Protocol in Head and Neck Cancer
NCT02460471 ·Status: COMPLETED ·Phase: PHASE2
-
Radiofrequency Ablation (RFA) in Breast Tumors
NCT04389216 ·Status: COMPLETED ·Phase: NA
-
Impact of a Process Optimizing the Decision to Continue or Stop Cancer Treatments in Patients With Advanced Non-small Cell Lung Cancer.
NCT04823377 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Descriptive Cohort of French Patients Treated With Carbonetherapy Since October 2010 Outside PHRC-ETOILE
NCT06535997 ·Status: COMPLETED
-
IORT in Local Advanced Laryngocarcinoma
NCT04278638 ·Status: UNKNOWN ·Phase: NA
-
Evaluation of the Efficacy of Radiofrequency in the Treatment of Renal Tumors
NCT02850809 ·Status: COMPLETED
-
Thermal Ablation Combined With External Beam Radiation Therapy for Patients With Inoperable Non-Small Cell Lung Cancer > 3.5 cm in Size
NCT01028612 ·Status: TERMINATED ·Phase: NA
-
Study of External Beam Radiotherapy to Thyroid Carcinoma
NCT01173289 ·Status: COMPLETED ·Phase: PHASE2
-
Hypofractionated Radiotherapy With 3.5 Gy Per Fraction for Early Glottic Cancer
NCT07197060 ·Status: NOT_YET_RECRUITING
-
Clinical Trial of Radiotherapy in Treating Primary Hepatocellular Carcinoma
NCT03614546 ·Status: UNKNOWN ·Phase: NA
-
Association of Conformational High-dose Radiotherapy and of Hyperselective Transarterial Chemoembolization in the Treatment of Hepatocellular Carcinoma
NCT01300143 ·Status: COMPLETED ·Phase: PHASE2
-
Remote Monitoring of Patient Reported Outcomes to Improve the Efficacy of the Acute Phase Radiotherapy Review Process
NCT06274892 ·Status: RECRUITING ·Phase: NA